Skip to main content

Gara Arteaga Henriquez

I am a specialist in Psychiatry and Doctor of Medicine (magna cum laude; Ludwig-Maximilian's University Munich, Germany). Additionally, I completed a post-doctoral stay at the National Center for Register-based Research at Aarhus University (Denmark). Since the beginning of my professional career, my interest has focused on the field of Immunopsychiatry and the search for diagnostic and therapeutic biological markers that allow us to improve the prognosis of various mental conditions/diseases, and also, contribute to reduce stigma. I have carried out numerous clinical and research stays at different reference centers in the field abroad, and I was selected by the European College of Neuropsychopharmacology to participate in its mentoring program which was aimed at expanding my knowledge in the field. I have more than 10 years of experience in conducting clinical trials with anti-inflammatory/immunomodulatory agents as well as with nutraceuticals, in the design and execution of different types of studies (clinical, register-based, cost-economic). Being a member of the CB15/00154 CIBERSAM group, I'm also leading and collaborating with different national and international projects in the field. Currently, I'm leading, both at a clinical and research level, the Immunopsychiatry line at the Hospital.

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

Gara Arteaga Henriquez

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

I am a specialist in Psychiatry and Doctor of Medicine (magna cum laude; Ludwig-Maximilian's University Munich, Germany). Additionally, I completed a post-doctoral stay at the National Center for Register-based Research at Aarhus University (Denmark). Since the beginning of my professional career, my interest has focused on the field of Immunopsychiatry and the search for diagnostic and therapeutic biological markers that allow us to improve the prognosis of various mental conditions/diseases, and also, contribute to reduce stigma. I have carried out numerous clinical and research stays at different reference centers in the field abroad, and I was selected by the European College of Neuropsychopharmacology to participate in its mentoring program which was aimed at expanding my knowledge in the field. I have more than 10 years of experience in conducting clinical trials with anti-inflammatory/immunomodulatory agents as well as with nutraceuticals, in the design and execution of different types of studies (clinical, register-based, cost-economic). Being a member of the CB15/00154 CIBERSAM group, I'm also leading and collaborating with different national and international projects in the field. Currently, I'm leading, both at a clinical and research level, the Immunopsychiatry line at the Hospital.

Publications: https://www.researchgate.net/scientific-contributions/Gara-Arteaga-Henriquez-2163021086

Projects

Eat2beNICE: Effects of Nutrition and Lifestyle on Impulsive, Compulsive, and Externalizing behaviors (Grant Nº 728018)

IP: José Antonio Ramos Quiroga
Collaborators: Carolina Ramos Sayalero, Marta Ribases Haro, Christian Fadeuilhe Grau, Silvia Alemany Sierra, Gara Arteaga Henriquez
Funding agency: EUROPEAN COMMISSION
Funding: 479789.91
Reference: EAT2BENICE_H2020-SFS2016
Duration: 01/09/2017 - 28/02/2023

Related news

Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.

A project led by the Vall d’Hebron Research Institute (VHIR) in collaboration with FIDMAG Germanes Hospitalàries Research Foundation describes structural and functional brain changes in adolescents with borderline personality disorder (BPD).

A large-scale study involving Vall d’Hebron confirms the genetic relatedness among 14 different psychiatric disorders and groups them into five new families, paving the way for new treatments targeting their shared underlying genetic causes

Related professionals

Urcuyo Delgado, Gabriela

Urcuyo Delgado, Gabriela

Research technician
Pediatric Neurology
Read more
Luis Morales Quinteros

Luis Morales Quinteros

Postdoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Anerkys Janett Uzcategui Sánchez

Anerkys Janett Uzcategui Sánchez

Gestió i Administració
Clinical Trials Economic Evaluation Unit
Commercial and Academic Clinical Research
Read more
Albert Vilanova Baldellou

Albert Vilanova Baldellou

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.